COLONIC N-ACETYLATION OF 5-AMINOSALICYLIC ACID IN INFLAMMATORY BOWEL-DISEASE

被引：81
|
作者：
ALLGAYER, H
AHNFELT, NO
KRUIS, W
KLOTZ, U
FRANKHOLMBERG, K
SODERBERG, HNA
PAUMGARTNER, G
机构：
[1] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,STUTTGART,FED REP GER
[2] UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,D-8000 MUNICH 70,FED REP GER
[3] PHARMACIA AB,UPPSALA,SWEDEN
来源：
GASTROENTEROLOGY | 1989年 / 97卷 / 01期
关键词：
D O I：
10.1016/0016-5085(89)91412-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：38 / 41
页数：4
相关论文
共 50 条
  • [31] Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid
    Bernstein, CN
    Eaden, J
    Steinhart, AH
    Munkholm, P
    Gordon, PH
    INFLAMMATORY BOWEL DISEASES, 2002, 8 (05) : 356 - 361
  • [32] 5-AMINOSALICYLIC ACID (5-ASA) RETENTION ENEMATA FOR LONG-TERM THERAPY OF INFLAMMATORY BOWEL-DISEASE (IBD)
    WYMAN, JB
    NUNEZ, JF
    PARENT, K
    NORFLEET, RG
    KIRCHNER, JP
    RYAN, ME
    RHODES, RA
    GASTROENTEROLOGY, 1985, 88 (05) : 1636 - 1636
  • [33] ACETYLATION OF 5-AMINOSALICYLIC ACID BY ISOLATED HUMAN COLONIC EPITHELIAL-CELLS
    IRELAND, A
    PRIDDLE, JD
    JEWELL, DP
    CLINICAL SCIENCE, 1990, 78 (01) : 105 - 111
  • [34] CLINICAL TOLERANCE TO 3 5-AMINOSALICYLIC ACID RELEASING PREPARATIONS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE INTOLERANT OR ALLERGIC TO SULFASALAZINE
    GIAFFER, MH
    OBRIEN, CJ
    HOLDSWORTH, CD
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1992, 6 (01) : 51 - 59
  • [35] Microproteinuria in patients with inflammatory bowel disease:Is it associated with the disease activity or the treatment with 5-aminosalicylic acid?
    Androniki C Poulou
    Konstantinos E Goumas
    Dimitrios C Dandakis
    Ioannis Tyrmpas
    Maria Panagiotaki
    Androniki Georgouli
    Dimitrios C Soutos
    Athanasios Archimandritis
    World Journal of Gastroenterology, 2006, (05) : 739 - 746
  • [36] SCAVENGING EFFECT OF 5-AMINOSALICYLIC ACID ON NEUTROPHIL-DERIVED OXIDANTS - POSSIBLE CONTRIBUTION TO THE MECHANISM OF ACTION IN INFLAMMATORY BOWEL-DISEASE
    TAMAI, H
    KACHUR, JF
    GRISHAM, MB
    GAGINELLA, TS
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (6-7) : 1001 - 1006
  • [37] 5-AMINOSALICYLIC ACID IS A POTENT INHIBITOR OF INTERLEUKIN 1-BETA PRODUCTION IN ORGAN-CULTURE OF COLONIC BIOPSY SPECIMENS FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
    MAHIDA, YR
    LAMMING, CED
    GALLAGHER, A
    HAWTHORNE, AB
    HAWKEY, CJ
    GUT, 1991, 32 (01) : 50 - 54
  • [38] 5-AMINOSALICYLIC ACID PREPARATIONS IN THE THERAPY OF CHRONIC INFLAMMATORY BOWEL DISEASES
    SCHEURLEN, C
    KRUIS, W
    INNERE MEDIZIN, 1992, 19 (03) : 88 - 93
  • [39] TREATMENT OF INFLAMMATORY BOWEL DISEASES - THE CURRENT ROLE OF 5-AMINOSALICYLIC ACID
    SCHOLMERICH, J
    GEROK, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (22) : 762 - 769
  • [40] DOES MAINTENANCE THERAPY WITH 5-AMINOSALICYLIC ACID COMPOUNDS SULFASALAZINE, OLSALAZINE OR MESALAZINE IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE CAUSE RENAL-DISEASE
    BOOTH, D
    KEATING, S
    BUCKLEY, M
    CROWE, J
    KELLIHER, D
    WEIR, DG
    OMORAIN, C
    GASTROENTEROLOGY, 1995, 108 (04) : A786 - A786
12345